Glycoprotein electrophoretic patterns have potential to monitor changes associated with neoplastic transformation in oral cancer

International Journal of Biological Markers

Volumn 27, Issue 3, 2012, Pages

  Vajaria, Bhairavi N ^a   Patel, Kinjal R ^a   Begum, Rasheedunnisa ^b   Patel, Jayendra B ^a   Shah, Franky D ^a   Shukla, Shilin N ^a   Patel, Prabhudas S ^a  

^a GUJARAT CANCER AND RESEARCH INSTITUTE   (India)

^b M S UNIVERSITY OF BARODA   (India)

Author keywords

Glycoproteins; Oral cancer; Oral precancerous conditions; Polyacrylamide gel electrophoresis

Indexed keywords

GLYCOPROTEIN; SCHIFF BASE;

ADOLESCENT; ADULT; AGED; ARTICLE; BIOLOGICAL MONITORING; CANCER PATIENT; CANCER RISK; CONTROLLED STUDY; FEMALE; HUMAN; LEUKOPLAKIA; MAJOR CLINICAL STUDY; MALE; MALIGNANT TRANSFORMATION; MOUTH CANCER; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN ELECTROPHORESIS; PROTEOMICS; STAINING; STATISTICAL SIGNIFICANCE; TOBACCO;

ADULT; CASE-CONTROL STUDIES; CELL TRANSFORMATION, NEOPLASTIC; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; GLYCOPROTEINS; HUMANS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; PRECANCEROUS CONDITIONS; YOUNG ADULT;

EID: 84867525260     PISSN: 03936155     EISSN: None     Source Type: Journal    
DOI: 10.5301/JBM.2012.9147     Document Type: Article

References (44)

1. Ahmedin J, Freddie B, Center M, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90.
2. Johnson NW, Warnakulasuria S, Gupta PC, et al. Global oral health inequalities in incidence and outcomes for oral cancer: causes and solutions. Adv Dent Res 2011; 23: 237-46.
3. Tanaka T, Ishigamori R. Understanding carcinogenesis for fighting oral cancer. J Oncol 2011; 2011: 603740.
4. Hashibe M, Brennan P, Chaung SC, et al. Interaction between tobacco and alcohol use and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. Cancer Epidemiol Biomarkers Prev 2009; 18: 541-50.
5. Neville BW, Day TA. Oral cancer and precancerous lesions. CA Cancer J Clin 2002; 52: 195-215.
6. Shah MH, Telang SD, Raval GN, Shah PM, Patel PS. Serum fucosylation changes in oral cancer and oral precancerous conditions: alpha-L-fucosidase as a marker. Cancer 2008; 113: 336-46.
7. Guo HB, Johnson H, Randolph M, Nagy T, Blalock R, Pierce M. Specific posttranslational modification regulates early events in mammary carcinoma formation. Proc Natl Acad Sci U S A 2010; 107: 21116-21.
8. Goldman R, Ressom HW, Varghes RS, et al. Detection of hepatocellular carcinoma using glycomic analysis. Clin Cancer Res 2009; 15: 1808-13.
9. Shah MH, Telang SD, Shah PM, Patel PS. Tissue and serum α-2-3 and α-2-6 linkage specific sialylation changes in oral carcinogenesis. Glycoconj J 2008; 25: 279-90.
10. Rajpura KB, Patel PS, Chawda JG, Shah RM. Clinical significance of total and lipid bound sialic acid levels in oral pre-cancerous conditions and oral cancer. J Oral Pathol Med 2005; 34: 263-7.
11. Raval GN, Parekh LJ, Patel DD, Jha FP, Sainger RN, Patel PS. Clinical usefulness of alterations in sialic acid, sialyltransferase and sialoproteins in breast cancer. Indian J Clin Biochem 2004; 19: 60-71.
12. Apweiler R, Hermjakob H, Sharon N. On the frequency of protein glycosylation, as deduced from analysis of the SWISS-PROT database. Biochim Biophys Acta 1999; 1473: 4-8.
13. Wang PH. Altered glycosylation in cancer: sialic acids and sialyltransferases. J Cancer Mol 2005; 1: 73-81.
14. Drake PM, Cho WO, Li B, et al. Sweetening the pot: adding glycosylation to the biomarker discovery equation. Clin Chem 2010; 50: 223-36.
15. Chorvath B, Dura J, Babusikova O, Gyarfas J. Cell surface proteins and glycoprotein electrophoretic patterns in some human hemopoietic malignancies. Neoplasma 1983; 30: 715-24.
16. Salasvov A, Sanchez-Hidalgo VM, Rabago VM, Sanchez LP, Vargas C, Salas VR. Polyacrylamide gel electrophoresis in human serum proteins in normal individuals and cancer patients. Arch Invest Med Mex 1980; 11: 31-47.
17. Baskies AM, Chretien PB, Weiss JF, et al. Serum glycoproteins in cancer patients. Cancer 1980; 45: 3050-60.
18. Zhang H, Cotler RJ. Glycoproteomics: new technology developments and applications provide renewed interest in glycoproteins. Clin Proteom 2008; 4: 1-4.
19. Corthals GL, Wasinger VC, Hochstrasser DF, Sanchez JC. The dynamic range of protein expression; a challenge for proteomic research. Electrophoresis 2000; 21: 1104-15.
20. Patel PS, Rawal RM, Raval GN, et al. Glycoprotein electrophoretic pattern in sera of patients with oral precancerous conditions and upper aerodigestive tract cancer. J Exp Clin Cancer Res 2007; 16: 65-70.
21. Glossman H, Neville D. Glycoproteins of cell surfaces. J Biol Chem 1971; 246: 6339-46.
22. Anderson M, Cawston T, Cheeseman GC. Molecular weights estimates of milk-fat-globule-membrane protein-sodium dodecyl sulphate complexes by electrophoresis in gradient acrylamide gels. Biochem J 1974;139: 653-60.
23. Chrostek L, Cylwik B, Krawiec A, Korcz W, Szmitkowski M. Relationship between serum sialic acid and sialylated glycoproteins in alcoholics. Alcohol Alcohol 2007; 42: 588-92.
24. Castellsague X, Quintana MJ, Martinez MC, et al. The role of type of tobacco and type of alcoholic beverage in oral carcinogenesis. Int J Cancer 2004; 108: 741-9.
25. Head and neck sites. In: Greene FI, Page DL, Fleming ID, et al, eds; American Joint Committee on Cancer (AJCC). Cancer staging manual, 6th ed. Philadelphia, PA: JB Lippincott 2002; 17-87.
26. Gowenlock AH, McMurray JR, McLauchlan DM, eds. Varley's practical clinical biochemistry, 6th ed. London: Heineman Medical Books 2006; 407-8.
27. Hames BD. An introduction to polyacrylamide gel electrophoresis. In: Hames BD, Rickwood D, eds. Gel electrophoresis of proteins. A practical approach. Oxford: IRL Press 1981; 1-91.
28. Rek A, Krenn E, Kungl AJ. Therapeutically targeting glycan interactions. Br J Pharmacol 2009; 157: 686-94.
29. Dall'Olio F. Protein glycosylation in cancer biology: an overview. J Clin Pathol Mol Pathol 1996; 49: 126-35.
30. Taneja N, Bathi RJ, Parveen S, Bhat K. Serum glycoproteins as prognosticator in oral cancer patients-A follow up study. Int J Oral Med Sci 2009; 8: 74-82.
31. Parwani RN, Parwani SR. Quantitative evaluation of serum fucose in oral squamous cell carcinoma patients. J Cancer Res Ther 2011; 7: 143-7.
32. Patel PS, Raval GN, Rawal RM, Patel MM, Balar DB, Patel DD. Importance of glycoproteins in human cancer. Indian J Biochem Biophys 1997; 34: 226-33.
33. Gebott MD, ed. Beckman microzone electrophoresis manual. Fullerton (CA): Beckman Instruments Division 1973; chapter 7: 7.1-7.6.
34. Patel PS, Adhvaryu SG, Balar DB, Parikh BJ, Shah PM. Clinical application of serum levels of sialic acid, fucose and seromucoid fraction as tumour markers in human leukemias. Anticancer Res 1994; 14: 747-51.
35. Balaram P, Sridhar H, Rajkumar T, et al. Oral cancer in southern India: the influence of smoking, drinking, paan-chewing and oral hygiene. Int J Cancer 2002; 98: 440-5.
36. Lin WJ, Jiang RS, Wu SH, Chen FJ, Liu SA. Smoking, alcohol, and betel quid and oral cancer. A prospective cohort study. J Oncol 2011; 2011: 525976.
37. Taylor AD, Hancock WS, Hincapic M, Taniguchi N, Hanash SM. Towards an integrated proteomic and glycomic approach to finding cancer biomarkers. Genome Med 2009; 1: 1-10.
38. Kyselova Z, Mechref Y, Kang P, et al. Breast cancer diagnosis and prognosis through quantitative measurements of serum glycan profiles. Clin Chem 2008; 54: 1166-75.
39. Mann B, Madera M, Klouchhova I, et al. A quantitative investigation of fucosylated serum glycoproteins with application to esophageal adenocarcinoma. Electrophoresis 2010: 31: 1833-41.
40. Zeng Z, Hincapie M, Pitteri SJ, et al. A proteomics platform combining depletion, multi-lectin affinity chromatography (M-LAC), and isoelectric focussing to study the breast cancer proteome. Anal Chem 2011; 83: 4845-54.
41. Liu Y, He J, Li C, et al. Identification and confirmation of biomarkers using an integrated platform for quantitative analysis of glycoproteins and their glycosylations. J Proteome Res 2010; 9: 798-805.
42. Goetz JA, Mechref Y, Kang P, Jeng MH, Novotny MV. Glycomic profiling of invasive and non-invasive breast cancer cells. Glycoconj J 2009; 26: 117-31.
43. Blomme B, Van Steenkiste C, Callewaert N, Van Vlierberghe H. Alteration of protein glycosylation in liver diseases. J Hepatol 2009; 50: 592-603.
44. Alley WR, Novotny MV. Glycomic analysis of sialic acid linkages in glycans derived from blood serum glycoproteins. J Proteome Res 2010; 9: 3062-72. cancer